Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research-Reference-Cited by-同舟云学术

Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research

Author:

Marcellin Fabienne¹²,Fontaine Hélène³⁴,Serfaty Lawrence⁵,Sogni Philippe⁶⁷,Carrieri Maria Patrizia¹²

Affiliation:

1. Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, Marseille, France

2. ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d’Azur, Marseille, France

3. INSERM, U1016, Hôpital Cochin, 27 rue du Faubourg Saint Jacques, Paris, France

4. Hepatology Unit, Groupe hospitalier Cochin-Hôtel Dieu, AP-HP, Paris, France

5. Service d'Hépato-Gastro-Entérologie et d'Assistance Nutritive, Hôpital de Hautepierre, Strasbourg, France

6. Service d’Hépatologie, AP-HP, Hôpital Cochin, Paris, France

7. Université Paris Descartes, Paris, France

Funder

French National Agency for Research on HIV/AIDS and viral hepatitis (ANRS)

French National Institute for Health and Medical Research (Inserm)

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

Reference35 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marijuana and HIV;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024

4. Cannabis in liver disorders: a friend or a foe?;European Journal of Gastroenterology & Hepatology;2018-11